213 related articles for article (PubMed ID: 33727082)
1. Transferrin-functionalized lipid nanoparticles for curcumin brain delivery.
Neves AR; van der Putten L; Queiroz JF; Pinheiro M; Reis S
J Biotechnol; 2021 Apr; 331():108-117. PubMed ID: 33727082
[TBL] [Abstract][Full Text] [Related]
2. Quercetin lipid nanoparticles functionalized with transferrin for Alzheimer's disease.
Pinheiro RGR; Granja A; Loureiro JA; Pereira MC; Pinheiro M; Neves AR; Reis S
Eur J Pharm Sci; 2020 May; 148():105314. PubMed ID: 32200044
[TBL] [Abstract][Full Text] [Related]
3. Brain-targeted delivery of resveratrol using solid lipid nanoparticles functionalized with apolipoprotein E.
Neves AR; Queiroz JF; Reis S
J Nanobiotechnology; 2016 Apr; 14():27. PubMed ID: 27061902
[TBL] [Abstract][Full Text] [Related]
4. In vivo Antiplasmodial Activity of Curcumin-Loaded Nanostructured Lipid Carriers.
Rashidzadeh H; Salimi M; Sadighian S; Rostamizadeh K; Ramazani A
Curr Drug Deliv; 2019; 16(10):923-930. PubMed ID: 31663477
[TBL] [Abstract][Full Text] [Related]
5. Effect of liquid-to-solid lipid ratio on characterizations of flurbiprofen-loaded solid lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs) for transdermal administration.
Song A; Zhang X; Li Y; Mao X; Han F
Drug Dev Ind Pharm; 2016 Aug; 42(8):1308-14. PubMed ID: 26707734
[TBL] [Abstract][Full Text] [Related]
6. Novel resveratrol nanodelivery systems based on lipid nanoparticles to enhance its oral bioavailability.
Neves AR; Lúcio M; Martins S; Lima JL; Reis S
Int J Nanomedicine; 2013; 8():177-87. PubMed ID: 23326193
[TBL] [Abstract][Full Text] [Related]
7. RVG29-Functionalized Lipid Nanoparticles for Quercetin Brain Delivery and Alzheimer's Disease.
Pinheiro RGR; Granja A; Loureiro JA; Pereira MC; Pinheiro M; Neves AR; Reis S
Pharm Res; 2020 Jul; 37(7):139. PubMed ID: 32661727
[TBL] [Abstract][Full Text] [Related]
8. Comparative study of nisoldipine-loaded nanostructured lipid carriers and solid lipid nanoparticles for oral delivery: preparation, characterization, permeation and pharmacokinetic evaluation.
Dudhipala N; Janga KY; Gorre T
Artif Cells Nanomed Biotechnol; 2018; 46(sup2):616-625. PubMed ID: 29688077
[TBL] [Abstract][Full Text] [Related]
9. Sucrose ester stabilized solid lipid nanoparticles and nanostructured lipid carriers. I. Effect of formulation variables on the physicochemical properties, drug release and stability of clotrimazole-loaded nanoparticles.
Das S; Ng WK; Tan RB
Nanotechnology; 2014 Mar; 25(10):105101. PubMed ID: 24531790
[TBL] [Abstract][Full Text] [Related]
10. Formulation, Characterization, and Cytotoxicity Evaluation of Lactoferrin Functionalized Lipid Nanoparticles for Riluzole Delivery to the Brain.
Teixeira MI; Lopes CM; Gonçalves H; Catita J; Silva AM; Rodrigues F; Amaral MH; Costa PC
Pharmaceutics; 2022 Jan; 14(1):. PubMed ID: 35057079
[TBL] [Abstract][Full Text] [Related]
11. Systematic development and characterization of curcumin-loaded nanogel for topical application.
Kesharwani P; Jain A; Srivastava AK; Keshari MK
Drug Dev Ind Pharm; 2020 Sep; 46(9):1443-1457. PubMed ID: 32644836
[TBL] [Abstract][Full Text] [Related]
12. Are nanostructured lipid carriers (NLCs) better than solid lipid nanoparticles (SLNs): development, characterizations and comparative evaluations of clotrimazole-loaded SLNs and NLCs?
Das S; Ng WK; Tan RB
Eur J Pharm Sci; 2012 Aug; 47(1):139-51. PubMed ID: 22664358
[TBL] [Abstract][Full Text] [Related]
13. Indinavir-Loaded Nanostructured Lipid Carriers to Brain Drug Delivery: Optimization, Characterization and Neuropharmacokinetic Evaluation.
Nasiri M; Azadi A; Zanjani MRS; Hamidi M
Curr Drug Deliv; 2019; 16(4):341-354. PubMed ID: 30674257
[TBL] [Abstract][Full Text] [Related]
14. Brain Delivery of Curcumin Using Solid Lipid Nanoparticles and Nanostructured Lipid Carriers: Preparation, Optimization, and Pharmacokinetic Evaluation.
Sadegh Malvajerd S; Azadi A; Izadi Z; Kurd M; Dara T; Dibaei M; Sharif Zadeh M; Akbari Javar H; Hamidi M
ACS Chem Neurosci; 2019 Jan; 10(1):728-739. PubMed ID: 30335941
[TBL] [Abstract][Full Text] [Related]
15. Curcumin-loaded nanostructured lipid carriers (NLCs) for nasal administration: design, characterization, and in vivo study.
Madane RG; Mahajan HS
Drug Deliv; 2016 May; 23(4):1326-34. PubMed ID: 25367836
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of Nanostructured Lipid Carriers Loaded Chitosan/ Carbopol Hybrid Nanocomposite Gel for Oral Delivery of Artemether and Curcumin.
Kumar A; Behl T; Uniyal T; Chadha S
Pharm Nanotechnol; 2020; 8(5):418-432. PubMed ID: 32895049
[TBL] [Abstract][Full Text] [Related]
17. Preparation, Characterization, and In vitro Evaluation of Curcumin- and Resveratrol-Loaded Solid Lipid Nanoparticles.
Gumireddy A; Christman R; Kumari D; Tiwari A; North EJ; Chauhan H
AAPS PharmSciTech; 2019 Mar; 20(4):145. PubMed ID: 30887133
[TBL] [Abstract][Full Text] [Related]
18. Biocompatible Lipid Nanoparticles as Carriers To Improve Curcumin Efficacy in Ovarian Cancer Treatment.
Bondì ML; Emma MR; Botto C; Augello G; Azzolina A; Di Gaudio F; Craparo EF; Cavallaro G; Bachvarov D; Cervello M
J Agric Food Chem; 2017 Feb; 65(7):1342-1352. PubMed ID: 28111949
[TBL] [Abstract][Full Text] [Related]
19. Solid lipid nanoparticles as a vehicle for brain-targeted drug delivery: two new strategies of functionalization with apolipoprotein E.
Neves AR; Queiroz JF; Weksler B; Romero IA; Couraud PO; Reis S
Nanotechnology; 2015 Dec; 26(49):495103. PubMed ID: 26574295
[TBL] [Abstract][Full Text] [Related]
20. Sucrose ester stabilized solid lipid nanoparticles and nanostructured lipid carriers. II. Evaluation of the imidazole antifungal drug-loaded nanoparticle dispersions and their gel formulations.
Das S; Ng WK; Tan RB
Nanotechnology; 2014 Mar; 25(10):105102. PubMed ID: 24531828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]